Crystallization, X-ray diffraction analysis and SIRAS phasing of human α-L-iduronidase

Area of Science:

• Biochemistry
• Structural Biology
• Genetics

Background:

• Mucopolysaccharidosis type I (MPS I) is a rare genetic disorder caused by deficiency of the enzyme α-L-iduronidase.
• Understanding the structure of human α-L-iduronidase is essential for developing targeted therapies for MPS I.

Purpose of the Study:

• To determine the high-resolution crystal structure of human lysosomal α-L-iduronidase.
• To provide a structural basis for understanding the enzymatic mechanism and disease pathology.

Main Methods:

• Crystallization of human α-L-iduronidase using sodium/potassium tartrate and polyethylene glycol 3350.
• X-ray diffraction data collection at 100 K using synchrotron radiation to 2.3 Å resolution.
• Phase determination using single-wavelength anomalous dispersion (SAD) on mercury-derivative crystals and the SIRAS method.

Main Results:

• The crystal structure of human α-L-iduronidase was determined in space group R3 with unit-cell dimensions a=b=259.22, c=71.83 Å.
• An interpretable electron-density map was obtained, enabling structural analysis.
• The study successfully resolved the three-dimensional structure of the enzyme.

Conclusions:

• The determined crystal structure provides a detailed molecular model of human α-L-iduronidase.
• This structural information is valuable for future drug design and gene therapy strategies for MPS I.
• The study advances our understanding of lysosomal enzyme structure and function.